Shetty Shrimati, Ghosh Kanjaksha, Mohanty Dipika
Institute of Immunohaematology (Indian Council of Medical Research), KEM Hospital, Parel, Mumbai, India.
Blood Coagul Fibrinolysis. 2003 Jul;14(5):493-7. doi: 10.1097/00001721-200307000-00011.
Large numbers of activated partial thromboplastin time (aPTT) reagents are sold in the market. The phospholipid content and its source, nature and the amount of activators are highly varied in different aPTT reagents. The present study was undertaken to evaluate which of the four aPTT reagents commonly used is suitable as an all-purpose reagent for a modest haemostasis laboratory. Four aPTT reagents (reagent A, Platelin LS; reagent B, Silimat; reagent C, Actin FSL; reagent D, CK Prest) were tested against 75 different plasmas obtained from normal patients as well as from patients with different haemostatic problems. All the tests were conducted by one of us (S.S.) in duplicates. Different aPTT reagents missed different proportions of mild factor VIII and factor IX deficiency (36.4, 18.2, 4.6 and 13.6% for reagents A, B, C and D, respectively) and showed abnormal results with normal plasmas (i.e. more than 5 s prolongation) (29.2, 25, 8.3 and 12.5% for reagents A, B, C and D, respectively). All the reagents faithfully picked up moderate and severe factor VIII and factor IX deficiency. There was no difference among the four aPTT reagents regarding their ability to prolong aPTT to therapeutic dosage of heparin or in their ability to give comparable factor VIII or factor IX levels in one-stage aPTT-based assays. There were differences in aPTT reagents in their ability to pick up mild deficiency of coagulation factor VIII and factor IX. Some reagents showed abnormal aPTT results in mild cases of factor VIII and factor IX deficiency without producing a large number of falsely prolonged aPTT with normal plasma.
市场上销售大量的活化部分凝血活酶时间(aPTT)试剂。不同的aPTT试剂中磷脂含量及其来源、性质和激活剂的量差异很大。本研究旨在评估四种常用的aPTT试剂中哪一种适合作为适度规模止血实验室的通用试剂。对四种aPTT试剂(试剂A,Platelin LS;试剂B,Silimat;试剂C,Actin FSL;试剂D,CK Prest)针对从正常患者以及有不同止血问题的患者获得的75种不同血浆进行了测试。所有测试均由我们其中一人(S.S.)进行了两次重复。不同的aPTT试剂漏检轻度因子VIII和因子IX缺乏的比例不同(试剂A、B、C和D分别为36.4%、18.2%、4.6%和13.6%),并且对正常血浆显示出异常结果(即延长超过5秒)(试剂A、B、C和D分别为29.2%、25%、8.3%和12.5%)。所有试剂都能准确检测出中度和重度因子VIII和因子IX缺乏。在将aPTT延长至肝素治疗剂量的能力或在基于一步法aPTT的检测中给出可比的因子VIII或因子IX水平的能力方面,四种aPTT试剂之间没有差异。aPTT试剂在检测凝血因子VIII和因子IX轻度缺乏的能力方面存在差异。一些试剂在因子VIII和因子IX轻度缺乏的情况下显示出异常的aPTT结果,而在正常血浆中不会产生大量错误延长的aPTT。